BLB&B Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $686K | Sell |
28,479
-1,664
| -6% | -$43.5K | 0.03% | 159 |
|
|
2026
Q1 | $846K | Sell |
30,143
-11,167
| -27% | -$297K | 0.04% | 138 |
|
|
2025
Q4 | $1.03M | Sell |
41,310
-504
| -1% | -$12.7K | 0.04% | 129 |
|
|
2025
Q3 | $1.07M | Sell |
41,814
-3,281
| -7% | -$81K | 0.05% | 121 |
|
|
2025
Q2 | $1.09M | Sell |
45,095
-5,319
| -11% | -$124K | 0.05% | 118 |
|
|
2025
Q1 | $1.28M | Sell |
50,414
-25,375
| -33% | -$664K | 0.07% | 112 |
|
|
2024
Q4 | $2.01M | Sell |
75,789
-14,242
| -16% | -$386K | 0.1% | 89 |
|
|
2024
Q3 | $2.61M | Sell |
90,031
-1,291
| -1% | -$37.7K | 0.13% | 77 |
|
|
2024
Q2 | $2.56M | Sell |
91,322
-14,983
| -14% | -$413K | 0.14% | 79 |
|
|
2024
Q1 | $2.95M | Sell |
106,305
-11,545
| -10% | -$320K | 0.17% | 72 |
|
|
2023
Q4 | $3.39M | Sell |
117,850
-26,892
| -19% | -$813K | 0.21% | 69 |
|
|
2023
Q3 | $4.8M | Sell |
144,742
-9,596
| -6% | -$339K | 0.34% | 59 |
|
|
2023
Q2 | $5.66M | Sell |
154,338
-5,909
| -4% | -$230K | 0.4% | 60 |
|
|
2023
Q1 | $6.54M | Sell |
160,247
-6,056
| -4% | -$262K | 0.49% | 52 |
|
|
2022
Q4 | $8.52M | Sell |
166,303
-7,633
| -4% | -$366K | 0.66% | 42 |
|
|
2022
Q3 | $7.61M | Sell |
173,936
-4,148
| -2% | -$202K | 0.63% | 41 |
|
|
2022
Q2 | $9.34M | Sell |
178,084
-7,683
| -4% | -$392K | 0.74% | 38 |
|
|
2022
Q1 | $9.62M | Sell |
185,767
-635
| -0.3% | -$32.9K | 0.65% | 43 |
|
|
2021
Q4 | $11M | Sell |
186,402
-12,950
| -6% | -$642K | 0.72% | 39 |
|
|
2021
Q3 | $8.57M | Sell |
199,352
-13,335
| -6% | -$591K | 0.57% | 48 |
|
|
2021
Q2 | $8.33M | Sell |
212,687
-30,343
| -12% | -$1.18M | 0.6% | 48 |
|
|
2021
Q1 | $8.8M | Sell |
243,030
-17,819
| -7% | -$633K | 0.69% | 38 |
|
|
2020
Q4 | $9.6M | Sell |
260,849
-13,295
| -5% | -$488K | 0.78% | 32 |
|
|
2020
Q3 | $9.55M | Sell |
274,144
-4,733
| -2% | -$166K | 0.96% | 26 |
|
|
2020
Q2 | $8.65M | Sell |
278,877
-15,575
| -5% | -$529K | 0.94% | 28 |
|
|
2020
Q1 | $9.12M | Sell |
294,452
-17,447
| -6% | -$594K | 1.19% | 22 |
|
|
2019
Q4 | $11.6M | Sell |
311,899
-15,504
| -5% | -$552K | 1.21% | 19 |
|
|
2019
Q3 | $11.2M | Sell |
327,403
-1,897
| -0.6% | -$69K | 1.26% | 19 |
|
|
2019
Q2 | $13.5M | Sell |
329,300
-6,386
| -2% | -$254K | 1.55% | 14 |
|
|
2019
Q1 | $13.5M | Buy |
335,686
+377
| +0.1% | +$15.1K | 1.59% | 13 |
|
|
2018
Q4 | $13.9M | Sell |
335,309
-12,049
| -3% | -$500K | 1.91% | 9 |
|
|
2018
Q3 | $14.5M | Buy |
347,358
+10,685
| +3% | +$411K | 1.81% | 11 |
|
|
2018
Q2 | $11.6M | Sell |
336,673
-69,552
| -17% | -$2.38M | 1.57% | 12 |
|
|
2018
Q1 | $13.7M | Buy |
406,225
+146,572
| +56% | +$5.04M | 1.83% | 11 |
|
|
2017
Q4 | $8.92M | Sell |
259,653
-7,025
| -3% | -$240K | 1.28% | 20 |
|
|
2017
Q3 | $9.03M | Sell |
266,678
-9,599
| -3% | -$309K | 1.39% | 19 |
|
|
2017
Q2 | $8.8M | Buy |
276,277
+1,443
| +0.5% | +$45.5K | 1.46% | 19 |
|
|
2017
Q1 | $8.92M | Buy |
274,834
+1,251
| +0.5% | +$39.4K | 1.52% | 19 |
|
|
2016
Q4 | $8.43M | Buy |
273,583
+129
| +0% | +$3.94K | 1.47% | 18 |
|
|
2016
Q3 | $8.79M | Buy |
273,454
+44
| +0% | +$1.47K | 1.6% | 14 |
|
|
2016
Q2 | $9.13M | Buy |
273,410
+9,828
| +4% | +$314K | 1.72% | 12 |
|
|
2016
Q1 | $7.41M | Buy |
263,582
+10,863
| +4% | +$310K | 1.49% | 14 |
|
|
2015
Q4 | $7.74M | Sell |
252,719
-3,717
| -1% | -$117K | 1.64% | 12 |
|
|
2015
Q3 | $7.64M | Buy |
256,436
+5,726
| +2% | +$184K | 1.69% | 11 |
|
|
2015
Q2 | $7.98M | Sell |
250,710
-1,126
| -0.4% | -$36.7K | 1.66% | 12 |
|
|
2015
Q1 | $8.31M | Buy |
251,836
+2,289
| +0.9% | +$72.8K | 1.73% | 11 |
|
|
2014
Q4 | $7.38M | Buy |
249,547
+2,406
| +1% | +$69K | 1.56% | 13 |
|
|
2014
Q3 | $6.93M | Sell |
247,141
-3,035
| -1% | -$85.2K | 1.5% | 14 |
|
|
2014
Q2 | $7.04M | Buy |
250,176
+2,313
| +0.9% | +$65.9K | 1.51% | 14 |
|
|
2014
Q1 | $7.55M | Sell |
247,863
-875
| -0.4% | -$26.1K | 1.66% | 10 |
|
|
2013
Q4 | $7.23M | Buy |
248,738
+2,395
| +1% | +$69.7K | 1.73% | 11 |
|
|
2013
Q3 | $6.71M | Sell |
246,343
-3,945
| -2% | -$107K | 1.77% | 10 |
|
|
2013
Q2 | $6.65M | Buy |
+250,288
| New | +$6.92M | 1.85% | 10 |
|
Other funds holding PFE
BLB&B Advisors's PFE Position: Q2 2026 in Review
BLB&B Advisors reduced its Pfizer (PFE) stake by 5.5% in Q2 2026, selling an estimated $43.5K and leaving 28,479 shares worth $686K. The position accounts for 0.03% of the portfolio, ranked #159.
BLB&B Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.5M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- BLB&B Advisors held 28,479 shares of Pfizer worth $686K as of Q2 2026.
- BLB&B Advisors sold 1,664 Pfizer shares in Q2 2026, an estimated $43.5K.
- Pfizer made up 0.03% of BLB&B Advisors's portfolio in Q2 2026, its #159 holding.
- BLB&B Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- BLB&B Advisors's Pfizer position peaked at $14.5M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on BLB&B Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.